Viral-load tests provide valuable answers

Same author

Measurement of plasma HIV-1 RNA below the limit of quantification (<20 copies/mL) of commercial assays with the integrase HIV RNA single-copy assay.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2018

Same author

HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells.

Science (New York, N.Y.)·2014

Same author

Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples.

Advances in virology·2012

Same author

Prevalence of XMRV nucleic acid and antibody in HIV-1-Infected men and in men at risk for HIV-1 Infection.

Advances in virology·2012

Same author

Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2010

Same author

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy.

Proceedings of the National Academy of Sciences of the United States of America·2009

Related Experiment Videos

Viral-load tests provide valuable answers

Related Concept Videos

Measurement of plasma HIV-1 RNA below the limit of quantification (<20 copies/mL) of commercial assays with the integrase HIV RNA single-copy assay.

HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells.

Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples.

Prevalence of XMRV nucleic acid and antibody in HIV-1-Infected men and in men at risk for HIV-1 Infection.

Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy.

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy.

Related Experiment Videos

Viral-load tests provide valuable answers

Related Concept Videos

Measurement of plasma HIV-1 RNA below the limit of quantification (<20 copies/mL) of commercial assays with the integrase HIV RNA single-copy assay.

HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells.

Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples.

Prevalence of XMRV nucleic acid and antibody in HIV-1-Infected men and in men at risk for HIV-1 Infection.

Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy.

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy.

Related Experiment Videos

Viral-load tests provide valuable answers

Related Concept Videos

Related Articles

Measurement of plasma HIV-1 RNA below the limit of quantification (<20 copies/mL) of commercial assays with the integrase HIV RNA single-copy assay.

HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells.

Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples.

Prevalence of XMRV nucleic acid and antibody in HIV-1-Infected men and in men at risk for HIV-1 Infection.

Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy.

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy.

Related Experiment Videos

Viral-load tests provide valuable answers

Related Concept Videos

Related Articles

Measurement of plasma HIV-1 RNA below the limit of quantification (<20 copies/mL) of commercial assays with the integrase HIV RNA single-copy assay.

HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells.

Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples.

Prevalence of XMRV nucleic acid and antibody in HIV-1-Infected men and in men at risk for HIV-1 Infection.

Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy.

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy.